Dagnon Terry 4
4 · Outlook Therapeutics, Inc. · Filed Dec 23, 2021
Insider Transaction Report
Form 4
Dagnon Terry
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-21+800,000→ 800,000 totalExercise: $1.44Exp: 2031-12-21→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on December 21, 2022, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances.